Claim:
Appeal from the grant of defense motion to dismiss, confirming applicability of the Indiana Medical Malpractice Act to the plaintiffs’ claims relating use of preservative-free methylprednisolone acetate from New England Compounding Company.
Outcome:
Motion to dismiss affirmed on appeal.
See Court of Appeals opinion here.
Partner
(219) 931-0560
Partner
219-931-0560
Partner
219-931-0560